Ruyin Liu

Prof. Dr. Ruyin Liu


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2022 in Folia Microbiologica
Verified
Journal Article
Closed access
PDF file
RLRuyin Liu
Ruyin Liu
GHGanghua Han
Ganghua Han
ZLZong Li
Zong Li
SCShujuan Cun
Shujuan Cun
BHBin Hao
Bin Hao
XLXinchun Liu
Xinchun Liu

7 February 2024 in Water Research
Verified
Journal Article
Closed access
ZLZong Li
Zong Li
XGXiaoxiao Guo
Xiaoxiao Guo
BLBingxin Liu
Bingxin Liu
THTing Huang
Ting Huang
RLRuyin Liu
Ruyin Liu
XLXinchun Liu
Xinchun Liu

28 June 2021 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
RLRuyin Liu
Ruyin Liu
ZLZong Li
Zong Li
GHGanghua Han
Ganghua Han
SCShujuan Cun
Shujuan Cun
MYMin Yang
Min Yang
XLXinchun Liu
Xinchun Liu

1 April 2019 in Water Research
Verified
Journal Article
Closed access
JZJunge Zhu
Junge Zhu
RLRuyin Liu
Ruyin Liu
NCNan Cao
Nan Cao
JYJianwei Yu
Jianwei Yu
XLXinchun Liu
Xinchun Liu
ZYZhisheng Yu
Zhisheng Yu

5 February 2023 in Water Research
Verified
Journal Article
Closed access
RLRuyin Liu
Ruyin Liu
ZLZong Li
Zong Li
GHGanghua Han
Ganghua Han
SCShujuan Cun
Shujuan Cun
DHDeyin Hou
Deyin Hou
XLXinchun Liu
Xinchun Liu

24 April 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GHGanghua Han
Ganghua Han
THTing Huang
Ting Huang
XLXinchun Liu
Xinchun Liu
RLRuyin Liu
Ruyin Liu
Edwardsiella piscicida causes significant economic losses to the aquaculture industry worldwide. Phage-based biocontrol methods are experiencing a renaissance because of the spread of drug-resistant genes and bacteria resulting from the heavy use of antibiotics. Here, we showed that the novel Edwardsiella phage EPP-1 could achieve comparable efficacy to florfenicol using a zebrafish model of Edwardsiella piscicida infection and could reduce the content of the floR resistance gene in zebrafish excreta. Specifically, phage EPP-1 inhibited bacterial growth in vitro and significantly improved the zebrafish survival rate in vivo (P = 0.0035), achieving an efficacy comparable to that of florfenicol (P = 0.2304). Notably, integrating the results of 16S rRNA sequencing, metagenomic sequencing, and qPCR, although the effects of phage EPP-1 converged with those of florfenicol in terms of the community composition and potential function of the zebrafish gut microbiota, it reduced the floR gene content in zebrafish excreta and aquaculture water. Overall, our study highlights the feasibility and safety of phage therapy for edwardsiellosis control, which has profound implications for the development of antibiotic alternatives to address the antibiotic crisis.